In February xxxx, it is anticipated that Omeprazole prices will exhibit a downward trend in both the North American and European region. This trend can be attributed to a recent decrease in demand for Omeprazole from downstream industries, along with sufficient supply in the market. Following increased demand in the previous month, market participants have stocked up on ample inventories of Omeprazole, which they now aim to clear out at reduced prices. Additionally, the decline in raw material prices, particularly pyridine, contributes to this trend. Muted trading activities and the absence of firm bids and offers from suppliers and distributors have kept pyridine prices from rising, leading to a decrease in the manufacturing cost of Omeprazole and subsequently lower prices.
China&#xx;s manufacturing activity in January likely contracted for the fourth consecutive month, albeit at a slower pace compared to December, indicating ongoing challenges for the...
